KVUE:NYSE
Kenvue Inc
USD 17.59
arrow_upward
+1.15%(+0.20) 1H
USD 17.59
0.00% (0.00)
bedtimeSelepas waktu pejabat
Ditutup: 6 Okt, 4:00:04 PTG GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk KVUE...
Buka
USD 17.46
Tinggi
USD 17.64
Rendah
USD 17.41
Permodalan Pasaran
33.42B
Purata volum
23.98J
Volum
10.87J
Dividen
4.78%
Dividen suku tahunan
USD 0.21
Tarikh tanpa dividen
21 Sep 2026
Nisbah H/P
20.39
tgi 52 mgu
USD 20.13
rdh 52 mgu
USD 14.02
EPS
USD 0.86
Beta
0.48
Syer tertunggak
1.92B
Bilangan pekerja
22K
Buka
USD 17.46
Tinggi
USD 17.64
Rendah
USD 17.41
Permodalan Pasaran
33.42B
Purata volum
23.98J
Volum
10.87J
Dividen
4.78%
Dividen suku tahunan
USD 0.21
Tarikh tanpa dividen
21 Sep 2026
Nisbah H/P
20.39
tgi 52 mgu
USD 20.13
rdh 52 mgu
USD 14.02
EPS
USD 0.86
Beta
0.48
Syer tertunggak
1.92B
Bilangan pekerja
22K
Cerita berita
Daripada sumber web dan rakan kongsi berita
AD HOC NEWS
·
1 jam lalu
Kenvue stock gained 1.15 percent as merger plans advance
Zacks
·
11 jam lalu
NWL or KVUE: Which Is the Better Value Stock Right Now?
Yahoo Finance UK
·
12 jam lalu
NWL or KVUE: Which Is the Better Value Stock Right Now?
Investing.com Canada
·
16 jam lalu
Form 4 Kenvue Inc For: 6 October By Investing.com
Profil
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Perihal Kenvue Inc
CEOKirk Perry
Pekerja21.9K
Diasaskan2022
Ibu pejabatSummit, New Jersey, Amerika Syarikat
SektorPersonal care products
Laman webkenvue.com